SCHEMBL301504

SCHEMBL301504

C[Si](C)(C)C[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1784891 0.65
SCHEMBL28753826 0.65
SCHEMBL1119968 0.62
SCHEMBL195841 0.61
SCHEMBL8755036 0.61
SCHEMBL28396651 0.59
SCHEMBL17732197 0.59
SCHEMBL787773 0.59
SCHEMBL18261219 0.56
SCHEMBL42931 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108165330-A A kind of method of one step recycling of plant and energy after soil remediation 中山大学 2018-06-15 CN claimed
CN-105461557-B Method for palladium/phosphite ligand catalyzed asymmetric allylic alkylation reaction 中国科学院兰州化学物理研究所 2017-04-26 CN claimed
US-7998986-B2 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors EXELIXIS PATENT COMPANY LLC (US) 2011-08-16 US claimed
EP-1465869-A4 MODULATORS OF LXR X CEPTOR THERAPEUTICS INC (US) 2005-12-28 EP claimed
JP-2005536450-A 2005-12-02 JP claimed
US-6838017-B1 Polar tolane liquid crystals HRL LABORATORIES, LLC (US) 2005-01-04 US claimed
WO-2004111062-A1 PARA-PHENYLENEDIAMINE DERIVATIVES COMPRISING A DIAZACYCLOHEPTANE RING SUBSTITUTED WITH A SILYL RADICAL, FOR DYEING KERATIN FIBRES L'OREAL (FR) 2004-12-23 WO claimed
EP-1465869-A1 MODULATORS OF LXR X-Ceptor Therapeutics, Inc. (US) 2004-10-13 EP claimed
CN-1481365-A Cyclization process steps for making quinolones and naphthyridines 2004-03-10 CN claimed
US-20030181420-A1 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors EXELIXIS, INC. 2003-09-25 US claimed
WO-2003059884-A1 MODULATORS OF LXR X-CEPTOR THERAPEUTICS, INC. (US) 2003-07-24 WO claimed
EP-1315783-A2 POLAR TOLANE LIQUID CRYSTALS HRL Laboratories, LLC (US) 2003-06-04 EP claimed
WO-2002020697-A2 POLAR TOLANE LIQUID CRYSTALS HRL LABORATORIES, LLC (US) 2002-03-14 WO claimed
CN-1092554-A Form the method for Micropicture SAMSUNG ELECTRONICS CO LTD (KR) 1994-09-21 CN claimed
CN-115594694-A Preparation method of delta 3-type capecitate 凌晟(武汉)生物医药技术有限公司(CN) 2023-01-13 CN disclosed
EP-4027993-A1 CYCLOOXYGENASE-2 INHIBITORS AND USES THEREOF The Broad Institute Inc. (US) 2022-07-20 EP disclosed
CN-113444117-B Star-shaped compound of BODIPY bridged tetraperylene diimide derivative and preparation method thereof 南京林业大学 2022-04-19 CN disclosed
CN-1119867-A Cephalosporin derivative YAMANOUCHI PHARMA CO LTD (JP) 1996-04-03 CN disclosed
WO-1988006603-A1 PREPARING GRAFT COPOLYMERS AND BRANCHED HOMOPOLYMERS Röhm GmbH Chemische Fabrik (DE) 1988-09-07 WO disclosed
US-4714777-A Cyclopropanone hydrate derivatives UNIVERSITY OF PITTSBURGH (US) 1987-12-22 US disclosed